Haemonetics Ownership | Who Owns Haemonetics?
Haemonetics Ownership Summary
Haemonetics is owned by 70.79% institutional investors, 1.19% insiders, and 28.02% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.44% of HAE shares. Neuberger Berman Genesis Inv is the top mutual fund, with 4.39% of its assets in Haemonetics shares.
HAE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Haemonetics | 70.79% | 1.19% | 28.02% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Medical Instruments & Supplies Stocks | 32.32% | 13.56% | 54.11% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 5.82M | 12.44% | $466.55M |
| Blackrock | 5.96M | 11.73% | $493.00M |
| Vanguard group | 4.76M | 10.18% | $381.60M |
| Neuberger berman group | 3.67M | 7.63% | $178.87M |
| State street | 1.80M | 3.74% | $87.77M |
| River road asset management | 1.65M | 3.44% | $80.65M |
| Goldman sachs group | 1.23M | 2.62% | $98.31M |
| Royal bank of canada | 1.26M | 2.62% | $61.45M |
| Geode capital management | 1.19M | 2.55% | $95.76M |
| Fmr | 1.22M | 2.53% | $59.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kestrel investment management | 98.10K | 4.46% | $7.86M |
| Sio capital management | 198.03K | 2.44% | $9.65M |
| Qsv equity investors | 14.03K | 1.66% | $1.12M |
| North peak capital management | 362.37K | 1.55% | $17.66M |
| Expect equity | 30.92K | 1.47% | $1.51M |
| Invenomic capital management lp | 498.32K | 1.18% | $24.29M |
| Aristotle capital boston | 404.16K | 1.02% | $19.70M |
| Riverwater partners | 31.01K | 0.96% | $2.49M |
| River road asset management | 1.65M | 0.90% | $80.65M |
| Keene & associates | 10.90K | 0.68% | $851.38K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 1.23M | 0.01% | 643.86K |
| Invenomic capital management lp | 498.32K | 1.18% | 470.50K |
| Fmr | 1.22M | 0.00% | 379.98K |
| North peak capital management | 362.37K | 1.55% | 362.37K |
| Man group | 503.12K | 0.04% | 341.30K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 317.13K | 0.00% | -1.83M |
| Capital research global investors | - | - | -1.14M |
| Ubs group | 539.68K | 0.01% | -912.89K |
| Sg capital management | - | - | -906.89K |
| Westfield capital management co lp | - | - | -805.92K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| North peak capital management | 362.37K | 1.55% | 362.37K | $17.66M |
| Arrowstreet capital, limited partnership | 126.07K | 0.00% | 126.07K | $6.14M |
| Norges bank | 125.93K | 0.00% | 125.93K | $10.09M |
| Weiss asset management lp | 107.66K | 0.06% | 107.66K | $5.25M |
| Neo ivy capital management | 40.78K | 0.66% | 40.78K | $3.37M |
Sold Out
| Holder | Change |
|---|---|
| Colonial trust co / sc | -1.00 |
| Rfp financial group | -1.00 |
| Tfc financial management | -1.00 |
| Tfo-tdc | -2.00 |
| Claris advisors, llc / mo / | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 236 | -24.84% | 33,122,441 | -35.46% | 70 | 0.62% | 108 | -32.08% | 94 | -16.81% |
| Sep 30, 2025 | 206 | -32.01% | 35,258,051 | -32.80% | 73 | 0.62% | 91 | -41.29% | 88 | -13.73% |
| Jun 30, 2025 | 309 | -6.93% | 54,411,783 | 0.83% | 113 | 0.98% | 158 | -12.22% | 103 | - |
| Mar 31, 2025 | 330 | -0.30% | 53,955,084 | -5.19% | 107 | 0.84% | 180 | 4.05% | 102 | 7.37% |
| Dec 31, 2024 | 177 | -44.51% | 31,118,376 | -43.80% | 61 | 0.52% | 94 | -38.16% | 49 | -56.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Neuberger Berman Genesis Inv | 2.11M | 4.39% | -80.85K |
| iShares Core S&P Mid-Cap ETF | 1.51M | 3.25% | -99.92K |
| Vanguard US Total Market Shares ETF | 1.60M | 3.19% | 1.18K |
| Vanguard Total Stock Mkt Idx Inv | 1.46M | 3.15% | 3.97K |
| Neuberger Genesis Inv | 1.42M | 3.05% | -340.63K |
| iShares Russell 2000 ETF | 1.16M | 2.50% | 65.40K |
| Vanguard Explorer Inv | 1.18M | 2.46% | - |
| Vanguard Small Cap Index | 1.06M | 2.28% | 194.00 |
| T. Rowe Price US Smlr Cm Eq A USD | 1.06M | 2.22% | -54.63K |
| American Funds SMALLCAP World A | 1.01M | 2.11% | -374.17K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 10, 2025 | KROLL MARK W | - | Buy | $98.78K |
| Jul 26, 2024 | Strong Stewart W | President, Global Hospital | Sell | $393.04K |
| Jul 12, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | $7.11K |
| Jul 11, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | Sell | $192.24K |
| May 29, 2024 | Basil Michelle L | EVP and General Counsel | Sell | $362.61K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 1 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 3 |
HAE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools